domain. In contrast to Src and other kinases, its C terminus is long and contains nuclear localization, nuclear export signals, and domains that are able to interact with DNA and F-actin (for recent reviews, see Refs. 22 and 23) . The intracellular distribution of Abl is very peculiar; among the various isoforms of Abl, one (type IV) is membrane-associated and another is soluble (type I). The latter can be found in either the cytosol or the nucleus. The cytosolic Abl interacts with the actin cytoskeleton (24) , whereas in the nucleus it can bind DNA and other proteins (25) .
Despite the large amount of experimental data on Abl, its functions are still not fully understood. In particular the molecular mechanisms connecting Drosophila Abl to disabled and enabled and mammalian Abl to mDab1 and Mena are not known. However, the opposite effects of the mutations of the enabled and disabled genes in Drosophila suggest that the products of these genes may be involved in the same molecular pathway. This conjecture is in agreement with the observations that both mDab1 and Mena participate in the protein-protein interaction network centered at the cytodomain of APP and supports the hypothesis that c-Abl also could be involved in the APP-centered molecular machinery. In this report we demonstrate that APP is tyrosine-phosphorylated in cells expressing a constitutively active form of Abl. Active Abl is tightly connected to the oligomeric complexes formed by APP, because Abl binds to the WW domain of Fe65 and is co-immunoprecipitated with APP.
EXPERIMENTAL PROCEDURES
Recombinant Constructs-The Fe65 and APP 695 expression constructs have been described (5) . Mouse c-Abl type IV cDNA, cloned into the pCDNA3 vector (Invitrogen), was a kind gift of A. Costanzo. Abl-PP expression vector and pGEX-Abl-SH2 (26) were kindly provided by D. Barilà and G. Superti-Furga. To generate the APPY653F, Y682F, and Y687A constructs, missense mutations in the APP 695 cDNA were introduced by the QuikChange TM site-directed mutagenesis kit (Stratagene) according to manufacturer's instructions, with the following six primer pairs (Ceinge): 5Ј-GGTGATGCTGAAGAAGAAACAGTTCACA-TCCATTCATCATGGTGTGG-3Ј; 5Ј-CCACACCATGATGAATGGATGT-GAACTGTTTCTTCTTCAGCATCACC-3Ј; 5Ј-CGGCTACGAAAATCCA-ACCGCCAAGTTCTTTGAGCAGATGC-3Ј; 5Ј-GCATCTGCTCAAAGA-ACTTGGCGGTTGGATTTTCGTAGCCG-3Ј; 5Ј-CCAAGATGCAGCAG-AACGGCTTCGAAAATCCAACCTACAAGTTCTTTG-3Ј; 5Ј-CAAAGAA-CTTGTAGGTTGGATTTTCGAAGCCGTTCTGCTGCATCTTGG-3Ј. The recombinant constructs were sequenced by the dideoxy terminator method with the Sequenase kit (Amersham Pharmacia Biotech) to confirm the inserted mutations. All plasmids were propagated following standard procedures (27) and purified on Qiagen Maxi-columns (Qiagen).
Cell Culture, Transfections, and Extract Preparation-COS7 african green monkey kidney cells were cultured in Dulbecco's modified minimal medium supplemented with 10% fetal calf serum at 37°C in a 5% CO 2 atmosphere. For transfection, 3 ϫ 10 6 cells were electroporated at 250 microfarad and 220 V with 5 g each of the indicated recombinant constructs. When multiple DNAs were co-transfected, the total amount of DNA was maintained constant by the addition of pRc-CMV empty vector DNA (Invitrogen). 36 h after transfection, cells were harvested in ice-cold phosphate-buffered saline and gently lysed in lysis buffer (50 mM Tris/HCl, pH 7.5, 150 mM sodium chloride, 0.5% Triton X-100, 10% glycerol, 50 mM sodium fluoride, 1 mM sodium vanadate) in the presence of a protease inhibitor mixture (Complete, Roche Molecular Biochemicals). The extracts were clarified by centrifugation at 16,000 ϫ g at 4°C, and the protein concentration was determined by the Bio-Rad protein assay according to manufacturer's instructions.
Pull-down, Co-immunoprecipitation, and Kinase Assays-The GST fusion proteins containing the SH2 domain of Abl or the WW, PTB1, and PTB2 domains of Fe65 were obtained by isopropyl-thiogalactoside induction of Escherichia coli cells harboring the corresponding constructs and purified from the bacterial lysates with glutathione-Sepharose resin (Amersham Pharmacia Biotech) according to the instructions of the manufacturer. For the pull-down experiments, purified fusion proteins were used to saturate glutathione-Sepharose beads (10 l) and challenged to transfected COS7 cell extracts (500 g/sample). Unbound proteins were removed by washing three times the beads with lysis buffer, while retained proteins were resolved by SDS-PAGE, electroblotted to polyvinylidene difluoride Immobilon-P membrane (Millipore) and analyzed by Western blot with the indicated antibodies. Loading of the GST proteins was checked by staining the filters with Ponceau S solution (Sigma).
Immunoprecipitations were carried out on COS7 lysates from transfected cells with the following antibodies: anti-Fe65 (5); anti-APP 369 (28) or anti-APP monoclonal antibodies 4G8 and 6E10 (Senetek PLC); anti-Abl Ab-3 monoclonal antibody; anti-phosphotyrosine PY99 (Santa Cruz Biotechnology); and rabbit preimmune sera and purified mouse IgGs (Sigma), which were used as control antibodies. Immune complexes were collected with 20 l of protein A/G plus Sepharose (Santa Cruz), washed three times for 5 min on a rotatory wheel at 4°C with lysis buffer, and separated on SDS-PAGE gels. The detection of proteins from immunoprecipitation experiments was achieved in Western blot experiments with the indicated above mentioned antibodies or with the anti-APP monoclonal antibody 22C11 (Chemicon), which was followed by enhanced chemiluminescence with the ECL kit (Amersham Pharmacia Biotech).
For the kinase assay (29) , washed immune complexes, obtained with anti-Abl sc-23 antibody (Santa Cruz) from Abl-PP-transfected COS7 cell extracts (100 g), were equilibrated in assay buffer (50 mM Tris/ HCl, pH 7.5, 5 mM manganese chloride, 1 mM dithiothreitrol) and washed. The kinase reaction was carried out at room temperature for 15 min by incubating the beads with 20 l of assay buffer in the presence of 1 g of synthetic 38-mer APP peptide (Primm) and 5 Ci of [␥-
32 P]ATP (3000 Ci/mmol, Amersham Pharmacia Biotech). The sequence of the synthetic 38-mer peptide is the following: K 6 DAAVT-PEERHLSKMQQNGYENPTYKFFEQMQN. Control reactions were carried out in the absence of any protein source and in the presence of nonspecific immune complex. The reaction products were fractionated onto 12.5% SDS-PAGE, stained with Coomassie R-250 (Bio-Rad), and exposed to autoradiographic films. For phosphopeptide analysis (30, 31) , the reaction products were resolved by SDS-PAGE and transferred to an Immobilon-P polyvinylidene difluoride membrane (Millipore). The labeled peptide band, visualized by autoradiography, was excised and subjected to hydrolysis in the presence of 6 N HCl for 90 min at 110°C. Lyophilized phospho-amino acids were resuspended in water and resolved by thin layer chromatography on cellulose-coated glass plates (Sigma) in propionic acid, 1 M ammonium hydroxide, 2-propanol solvent (45/17.5/17.5, v/v/v). Detection of the labeled sample was by autoradiography. Phospho-amino acid standards L-phosphoserine, L-phosphothreonine, and L-phosphotyrosine (Sigma) were run on adjacent lanes and detected by ninhydrin spraying.
RESULTS

Abl Interacts with the WW Domain of the Fe65 Adaptor
Protein-It was recently hypothesized that Abl could interact with APP through the adaptor proteins, which are known to bind to the APP cytodomain (32) . We explored the possibility that Fe65, one of the multimodular proteins that forms complexes with APP, could be one of the adaptors that tethers Abl to the cytodomain of APP. To address this point we performed pull-down experiments in which GST-Fe65 fusion proteins were used as baits to entrap Abl from extracts of COS7 cells transfected with plasmid vectors driving the expression of type IV mouse c-Abl or of Abl-PP, in which the mutation of two prolines of c-Abl (Pro 242 and Pro 249 ), located between the SH2 domain and the TK domain, results in a constitutive TK activity (33) . As shown in Fig. 1A , both PTB domains of Fe65 do not interact with Abl-PP. On the contrary, Abl-PP is affinity-purified by the GST-Fe65 fusion protein containing the WW domain. A similar result was observed by using the extracts from cells transfected with c-Abl, which similarly interacts only with the GST-Fe65-WW protein.
This interaction between Fe65 and Abl, observed in vitro, was analyzed in extracts from COS7 cells transfected with c-Abl or Abl-PP and immunoprecipitated with the Fe65 antibody. As shown in Fig. 1B , this experiment demonstrated that the constitutively active Abl-PP mutant is present in the proteins immunoprecipitated by Fe65 antibody (see lane 2), whereas c-Abl is not (see lane 9) . Looking at the amino acid sequence of Abl, there is at least one motif that can be recognized by the WW of Fe65 (PPPPPA) located between amino acids 899 and 904 (13, 34) .
The Cytosolic Domain of APP Is Tyr-phosphorylated in Cells Expressing a Constitutively Active Form of Abl-The Fe65-Abl-PP interaction supports the hypothesis that Fe65 functions as a docking site to bring Abl close to phosphorylation targets. To evaluate whether Fe65 itself is a target of Abl TK, the same blot of Fig. 1B was challenged with an anti-pTyr antibody. This experiment demonstrated that Fe65 is not recognized by this antibody (see Fig. 1B, lane 4) , and therefore its tyrosine phosphorylation is unlikely. It was documented that APP is phosphorylated on Ser and Thr in vitro and in vivo (35, 36) . However, APP was never observed to be Tyr-phosphorylated. We analyzed the possibility that Tyr residues present in the cytodomain of APP are substrates of Abl TK activity. To this aim, COS7 cells were transfected with an APP 695 expression vector and/or with the vector driving the expression of Abl-PP. Fig. 2A shows that proteins immunoprecipitated using the APP antibody contained a band of the same size as that of APP and clearly stained with an anti-phosphotyrosine antibody only in cells that express the constitutively active mutant form of Abl (see lane 2). Conversely, APP is present in the proteins immunoprecipitated with the anti-pTyr antibody, again only in cells expressing the active form of Abl (see Fig. 2A, lanes 6 and 7) .
To evaluate whether the band immunoprecipitated by the APP antibody and stained by the anti-pTyr antibody is the consequence of a Tyr phosphorylation of the APP cytosolic domain, a peptide was synthesized on the basis of the Cterminal sequence of APP, common to all the APP isoforms. This peptide was incubated in the presence of [␥-
32 P]ATP with an Abl-immunoprecipitated extract of COS7 cells expressing Abl-PP. Fig. 2B shows the autoradiography of the SDS-PAGE gel and the peptide results to be 32 P-labeled only when incubated with the proteins immunoprecipitated with the Abl antibody and not with the proteins immunoprecipitated with unrelated antibodies. The labeled band was transferred onto a polyvinylidene difluoride filter, and the peptide was hydrolyzed as described under "Experimental Procedures." The resulting amino acids were separated by thin layer chromatography, and 32 P-labeled amino acids were detected by autoradiography. Fig.  2C shows that the only 32 P-labeled residue found in the hydrolyzed peptide was phosphotyrosine.
There are three tyrosines located in the cytodomain of APP (residues 653, 682, and 687 of APP 695 ). To analyze their involvement in the above described phenomena, we generated three mutant APP 695 expression vectors in which Tyr 653 or Tyr 682 has been changed into phenylalanine or Tyr 687 has been changed into alanine. These vectors were transfected in COS7 cells with the Abl-PP-expressing vector. As shown in Fig. 2D , the APP-Y653F and APP-Y687A are recognized by the antipTyr antibody, whereas the APP-Y682F is not; this suggests the hypothesis that Tyr 682 is the actual target of the phosphorylation of the citodomain of APP. This result is in agreement with the data concerning the substrate preference of protein tyrosine kinases, indicating that c-Abl preferentially phosphorylates proteins at the level of the YXXP motif (37) , where X are hydrophilic residues, which fits with the YENP sequence we found to be phosphorylated in APP.
APP Co-immunoprecipitates with the Active Form of AblThe Western blot experiment of Fig. 2A (see lane 2) , in addition to the APP bands also shows a slower migrating band recognized by the anti-pTyr antibody and co-immunoprecipitated by the APP antibody. This band is present only in the samples from COS7 cells co-transfected with Abl-PP, and its size is compatible with that of Abl itself. This possibility was analyzed in the experiments reported in Fig. 3 ; panel A shows the Western blot analysis with Abl antibody of proteins immunoprecipitated by APP antibody that demonstrated the presence of Abl in the immunoprecipitates. The co-immunoprecipitation of Abl with APP has been observed also in cells not transfected with APP (see Fig. 3A, lane 3) , thus suggesting that the transfected, active Abl could also be co-immunoprecipitated with endogenous APP 751 , present in significant amounts in COS7 cells. The co-immunoprecipitation of APP and Abl was confirmed in the experiment reported in Fig. 3B , in which protein extracts from COS7 cells were immunoprecipitated with Abl antibody and blotted with APP. Also in this case APP is present in the extract immunoprecipitated by the Abl antibody.
It was demonstrated that the various known protein tyrosine kinases phosphorylate Tyr-containing sites that, upon phosphorylation, are recognized by their own or closely related SH2 domains (38) . This finding suggests that the phosphorylation of the APP cytodomain at the level of the YENP motif generates a new motif, pYXXP, that could interact with Abl SH2 domain. To examine this point, COS7 cells were transfected with APP695 or with APP695 and Abl-PP expression vectors. Total extracts from these cells were analyzed in pull-down experiments using a GST fusion protein containing the SH2 domain of Abl. As shown in Fig. 3C , GST-Abl-SH2 protein is able to bind to APP only in cells overexpressing active Abl, thus supporting the hypothesis that tyrosine-phosphorylated APP can form complexes with Abl through the Abl SH2 domain. In any case, it is worth noting that the APP Y682F mutant, which is not tyrosine-phosphorylated, still co-immunoprecipitates with Abl, thus suggesting that in addition to an APP-Abl interaction mediated by the SH2 domain, other complexes could contain both APP and Abl. DISCUSSION We addressed the question of the possible involvement of Abl in the protein-protein interaction network centered at the cytosolic domain of APP and found that APP is tyrosine-phosphorylated in cells expressing a constitutively active Abl. In addition we showed that this protein forms complexes with Fe65 and with APP itself. Our results suggest that Fe65 could bind at the same time APP, through its PTB2 domain, and Abl, through its WW domain, thus allowing the formation of a heterotrimeric complex. As a consequence of this interaction, active Abl is docked close to the APP cytodomain, and this could favor the phosphorylation of its Tyr 682 (see a hypothetical model in Fig. 4) . The observed co-immunoprecipitation of Tyrphosphorylated APP and Abl could be the consequence of APPAbl interaction through the SH2 domain of Abl, which has a high affinity for the pYXXP motif (38) . Furthermore, the phosphorylation of Tyr 682 is expected to be deleterious for the binding of the PTB domains of Fe65, X11, and mDab1 because it was demonstrated that, at least for Fe65 and X11, this residue is crucial for the formation of the complexes with APP (3), and it is a hydrophobic residue in most of the known PTB binding sites (39) .
As reported in Fig. 4 , there are several lines of evidence suggesting that Abl, mDab1, and Mena are involved in common molecular machineries. It was, in fact, demonstrated that mDab1 binds through its PTB domain with the cytosolic domain of APP (7, 8) and that Mena interacts with the WW domain of Fe65 (13) , which, in turn, interacts with APP. Considering the results reported in this paper, it can be hypothesized that Abl, mDab1, and Mena compete for the anchoring to the same intracellular site: mDab1 by competing with Fe65 for the binding to the cytodomain of APP; and Abl and Mena by competing for the binding to the WW domain of Fe65 (Fig. 4) .
It is worth noting that the Tyr 682 of human APP 695 and the YENP motif are both conserved among all the known APPs in primates, rodents, Drosophila, and Caenorhabditis and are present also in the APP-related proteins APLP1 and APLP2. Considering that the overall sequence identity between Drosophila APP (Appl) and the mammalian APPs is less than 30%, the 100% conservation of the cytosolic motif containing the phosphorylated tyrosine suggests that it plays a key functional role. This means that the understanding of the molecular basis of the different phenotypes observed in insects bearing mutations of Drosophila Abl (DAbl) and/or disabled and/or enabled should also take into account the involvement of APP. Appl null flies show behavioral defects that are rescued by human APP, and the possible correlation with the defects caused by DAbl, disabled, and enabled gene mutations is not apparent. However, one could gain better insight by the analysis of the phenotypes of insects bearing combined mutations of Appl with the other three genes. For example, the effects of disabled gene mutation on the Abl Ϫ/Ϫ flies also could be the consequence of the direct interaction of these two proteins with APP, whereas the amelioration observed in Drosophila Abl Ϫ/Ϫ disabled Ϫ/Ϫ following the mutation of the enabled gene could be also based on the competition between the enabled and DAbl gene products for the binding to Appl through Drosophila Fe65.
Although the WW domain of Fe65 interacts in vitro with both c-Abl and Abl-PP, only the complexes between Fe65 and the active form of Abl, and not those with the wild type c-Abl, were found in cell extracts. This effect could be due to a lower amount of c-Abl than Abl-PP available for the formation of the in vivo complexes; or it could be due to a low affinity of c-Abl for the WW domain of Fe65 so that, in vivo, it cannot form a significant number of complexes with Fe65 because of the competition of the other ligands of the WW domain of this protein. Furthermore, active Abl probably has a different conformation than c-Abl, thus acquiring a higher affinity for the WW domain. On the contrary, the APP-Abl direct interaction probably requires an active Abl, because the binding is based on a pTyr-SH2 interaction.
It has been hypothesized often that APP could have some role in signaling, and in a recent review article, Bothwell and Giniger (32) suggested the possibility that intracellular signaling could be involved in the development of AD. Their hypothesis takes into account the numerous reports on various proteins that could be involved in the pathogenesis of AD and suggests a role for c-Abl as a modulator of APP biology. Our results support their hypothesis. A point that deserves attention, besides those discussed in the mentioned review article, concerns the possible involvement of p73 in the molecular machinery under examination. In fact, this protein is a key regulator of apoptosis that binds to and is activated by Abl as a response to DNA damage (40 -42) . An isoform of p73 functions as an anti-apoptotic protein in developing neurons (43) , and the role of its phosphorylation by Abl has not been addressed. The finding that active Abl binds to APP suggested an examination of the possible regulatory effects of this binding on the p73 phosphorylation by Abl and the consequences on this regulation of the enhanced APP proteolytic processing characteristic of AD.
Our results support the hypothesis that Fe65 connects Abl to the APP-centered molecular machinery. However, other possible roles of the Fe65⅐Abl complex should be examined, as for example those suggested by the observation that both Fe65 and Abl, further than in the cytoplasm, are also localized in the nucleus (24, 44) .
